Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study by Ada Gillissen, Thomas van den Akker,

Slides:

Advertisements

Similar presentations

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.

Advertisements

Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.

Massive transfusion: New Protocol

Increased peripheral platelet destruction and caspase-3– independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients by.

Box and Whisker Plots Example: Comparing two samples.

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.

Severe maternal morbidity in ectopic pregnancy is not associated with maternal factors but may be associated with quality of care Norah M. van Mello,

Shortened Coagulation profile in Pregnancy - A Comparative analysis in different trimesters: Retrospective study from a tertiary care centre Bhavika Rishi,

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis by Samantha C. Gouw, H. Marijke.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase.

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup by Marie-Anne Hospital, Thomas Prebet,

A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma by Jean-Louis H. Kerkhoffs,

International Journal of Surgery

Bleeding in carriers of hemophilia

Nonmyeloablative conditioning for relapsed follicular lymphoma

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.

Reproductive capacity in iron overloaded women with thalassemia major

by Jessica A. Reese, Xiaoning Li, Manfred Hauben, Richard H

by Kenneth Weinberg, Bruce R. Blazar, John E

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor.

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population by Sumithira Vasu,

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study by Daniel J. DeAngelo, Wendy.

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes by Raphael Itzykson, Simon Crouch, Erica Travaglino, Alex Smith,

Graph (box plots) shows primary tumor volumes of oral and maxillary sinus (A) and pharyngeal (B) cancers categorized at T1–T4. Graph (box plots) shows.

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the.

Sunday Physiotherapy Reduces Inpatient Stay in Knee Arthroplasty: A Retrospective Cohort Study Yong-Hao Pua, PhD, Peck-Hoon Ong, BAppSc(Phty), Hwei-Chi.

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Box and Whisker Plot of the Distribution of Perceived Stress Scores for TMD Controls and TMD CasesThe horizontal line within the box is the median value.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD by Nelli Bejanyan, Claudio G. Brunstein,

Volume 80, Issue 4, Pages (August 2011)

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study by C. Madsen, M. R. Clausen, T. L. Plesner,

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea by Françoise Bernaudin, Cécile Arnaud,

Intraoperative autotransfusion in aortic surgery: Comparison of whole blood autotransfusion versus cell separation Claus Bartels, MD, J.V. Matthias Bechtel,

by Dana T. Lounder, Qiong Bin, Cristina de Min, and Michael B. Jordan

Retrospective analysis of capillary hemoglobin recovery in nearly 1 200 000 blood donor returns by Pia Niittymäki, Mikko Arvas, Antti Larjo, Pirkko Mattila,

by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A

Intensity of statistical methods and reporting subdivided by the journal groups. Intensity of statistical methods and reporting subdivided by the journal.

by Kaiwen Chen, Matthew P. Cheng, Sarah P

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease by Margaret T. Lee, Meyer Kattan,

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.

Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study by Marius Flasinski, Kira Scheibke, Martin Zimmermann,

by Christine L. Kempton, and Amanda B. Payne

Between-country and within-country variability in the number of nursing care activities left undone—composite score in 488 European hospitals. Between-country.

by Michael R. DeBaun, and Ellen Wright Clayton

Ontogeny of platelet function

by Jens Kjeldsen-Kragh, Thomas L

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Box-and-whisker plot of attenuation measurements with DE and SECT

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.

Fibrinogen plasma concentration before delivery is not associated with postpartum haemorrhage: a prospective observational study O. Karlsson, A. Jeppsson,

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors by Midori Shima, Hideji Hanabusa,

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

by Andrew L. Gilman, Michael J

Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera by Nikolai A. Podoltsev, Mengxin.

A first-in-human phase 1 study of ACE910, a novel factor VIII–mimetic bispecific antibody, in healthy subjects by Naoki Uchida, Takehiko Sambe, Koichiro.

Circulating plasma inflammatory and apoptosis biomarker concentrations on day 1 and day 8, stratified by intensity of RRT. Boxplot summaries of plasma.

The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia by Amy K. Keating, Jurgen Langenhorst, John.

Comparison of the meanSS and maxSS was determined by using MRE among tumors with an intraoperative consistency scale of 1–3 that were nonfirm and those.

Fig. 2 Particles detected in snow samples collected at different locations from Europe to the Arctic. Particles detected in snow samples collected at different.

New concepts for anticoagulant therapy in persons with hemophilia

Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.

Presentation transcript:

Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study by Ada Gillissen, Thomas van den Akker, Camila Caram-Deelder, Dacia D. C. A. Henriquez, Kitty W. M. Bloemenkamp, Moniek P. M. de Maat, Jos J. M. van Roosmalen, Joost J. Zwart, Jeroen Eikenboom, and Johanna G. van der Bom BloodAdv Volume 2(19):2433-2442 October 9, 2018 © 2018 by The American Society of Hematology

Ada Gillissen et al. Blood Adv 2018;2:2433-2442 © 2018 by The American Society of Hematology

Inclusion flowchart for “Coagulation Parameters during the Course of Severe Postpartum Hemorrhage: A Nationwide Retrospective Cohort Study.”. Inclusion flowchart for “Coagulation Parameters during the Course of Severe Postpartum Hemorrhage: A Nationwide Retrospective Cohort Study.” Ada Gillissen et al. Blood Adv 2018;2:2433-2442 © 2018 by The American Society of Hematology

Coagulation parameters of women during the course of severe postpartum hemorrhage per categorized amount of blood loss. Coagulation parameters of women during the course of severe postpartum hemorrhage per categorized amount of blood loss. (A) Hemoglobin, (B) hematocrit, (C) platelet count, (D) fibrinogen, (E) aPTT, and (F) PT. Laboratory parameters are presented in box plots. Circles are outliers. The box represents the 25th and 75th percentiles, and the whiskers are the upper and lower adjacent values. Ada Gillissen et al. Blood Adv 2018;2:2433-2442 © 2018 by The American Society of Hematology

Coagulation parameters of women with and without combined end point of severe acute maternal morbidity or mortality per categorized amount of blood loss. Coagulation parameters of women with and without combined end point of severe acute maternal morbidity or mortality per categorized amount of blood loss. (A) Hemoglobin, (B) hematocrit, (C) platelet count, (D) fibrinogen, (E) aPTT, and (F) PT. Box plots of coagulation parameters per categorized amount of blood loss comparing women experiencing postpartum hemorrhage with and without the composite adverse outcome. Morbi-mortality comprises the composite adverse outcome of severe acute maternal morbidity, mortality, or need for surgical intervention. Circles are outliers. The box represents the 25th and 75th percentiles, and the whiskers are the upper and lower adjacent values. Ada Gillissen et al. Blood Adv 2018;2:2433-2442 © 2018 by The American Society of Hematology